The study will explore whether if the use of Orlistat results in weight loss that is
accompanied by a reduction in the body burdens of polybrominated biphenyls (PBB) and other
Persistent Organic Pollutants (POPs).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Emory University
Collaborators:
Healthway Compounding Pharmacy in central Michigan Michigan Public Health Departments